Related Experiment Video
Updated: Jun 16, 2026
Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Coagulation profiling of random-source cats
Elizabeth McGeehan1, Karen Wielgus, Lee Cera
1Department of Comparative Medicine, Loyola University Medical Center, Maywood, Illinois, USA. emcgeehan@lumc.edu
Insights
Class B vendor cats show significant variations in coagulation and antiprotease activities, potentially impacting their suitability for cardiovascular research. These findings highlight the need for careful consideration of feline health status in research settings.
Area of Science:
- Veterinary Medicine
- Hematology
- Comparative Physiology
Background:
- Class B vendor cats (Felis catus) exhibit variable health statuses.
- Hemostatic parameters and antiprotease activities can differ significantly between animal populations.
- Understanding coagulation profiles is crucial for animal research subject selection.
Purpose of the Study:
- To compare hemostatic parameters and antiprotease activities between Class B vendor cats and healthy control cats.
- To assess the variability of coagulation factors in Class B vendor cats.
- To determine the suitability of Class B vendor cats for vascular or cardiovascular research.
Main Methods:
- Comparison of prothrombin time, partial thromboplastin time, common pathway assay, and thrombin time.
- Measurement of antiprotease activities: anti-factor Xa (antiXa), anti-factor IIa (antiIIa), heparin cofactor II, and antithrombin.
- Analysis of plasma samples using standard clotting and chromogenic substrate assays.
- Statistical analysis including tests for homogeneity of variances and one-way ANOVA.
Main Results:
- Significant differences were observed between groups for heparin cofactor II and Heptest activity levels.
- Prothrombin time showed significant variance differences between groups, precluding ANOVA.
- Class B vendor cats displayed wide variations in coagulation parameters compared to controls.
Conclusions:
- Class B vendor cats exhibit substantial variability in coagulation and antiprotease activities.
- The wide variations suggest Class B cats may not be optimal subjects for vascular or cardiovascular research.
- Initial health status likely contributes to the observed hemostatic parameter variations in vendor cats.
Abstract:
The chemistry and hemostatic parameters of class B vendor cats (Felis catus) can show wide levels of variation, possibly because of initial health status. We compared prothrombin time, partial thromboplastin time, common pathway assay and thrombin time between Class B vendor cats (n = 30) and a control group of healthy cats (n = 16). The antiprotease activities of antiXa, antiIIa, heparin cofactor II, and antithrombin were measured also. Plasma samples from citrated blood were analyzed by using standard clotting assays and commercially available chromogenic substrate assays. Tests for homogeneity of variances and 1-way ANOVA were used to test for significant differences between groups. Results of ANOVA were highly significant between groups for heparin cofactor II and Heptest activity levels. Variances were significantly different between groups for prothrombin time; therefore, an ANOVA was not done. These studies suggest that the class B cats exhibited sufficiently wide variations in their coagulation parameters that they may not be optimal subjects for vascular or cardiovascular research.
